InMed Pharmaceuticals Inc
(NAS:INM)
$
0.263
0.0095 (3.75%)
Market Cap: 2.35 Mil
Enterprise Value: -4.18 Mil
PE Ratio: 0
PB Ratio: 0.15
GF Score: 28/100 InMed Pharmaceuticals Inc (INM) Transcripts
- InMed Pharmaceuticals Inc Investor Summit TranscriptJun 01, 2023
- InMed Pharmaceuticals Inc at OTC Markets Life Science Investor Forum (Virtual) TranscriptMar 09, 2023
- InMed Pharmaceuticals Inc at Emerging Growth Conference TranscriptMar 08, 2023
- Q4 2022 InMed Pharmaceuticals Inc Earnings Call TranscriptSep 23, 2022$5.57 (-19.51%)Earnings
- Q4 2021 InMed Pharmaceuticals Inc Earnings Call TranscriptSep 24, 2021$45.5 (-0.55%)Earnings
- Q3 2021 InMed Pharmaceuticals Inc Earnings Call TranscriptMay 13, 2021$70.25 (-16.86%)Earnings
- Q2 2021 InMed Pharmaceuticals Inc Earnings Call TranscriptFeb 11, 2021$133.75 (+6.15%)Earnings
- Q3 2020 InMed Pharmaceuticals Inc Earnings Call TranscriptMay 14, 2020$174.16 (-4.70%)Earnings
- Q2 2020 InMed Pharmaceuticals Inc Earnings Call TranscriptFeb 14, 2020$206.33 (-1.88%)Earnings
- 1